Veterinary Medicines

T-61, otopina za injekciju, za pse, mačke, druge male životinje, ptice i velike životinje

Authorised
  • Tetracaine hydrochloride
  • Mebezonium iodide
  • Embutramide
Download as PDF

Product identification

Medicine name:
T-61, otopina za injekciju, za pse, mačke, druge male životinje, ptice i velike životinje
Active substance:
  • Tetracaine hydrochloride
  • Mebezonium iodide
  • Embutramide
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Intrapulmonary use
  • Intracardiac use

Product details

Active substance and strength:
  • Tetracaine hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Mebezonium iodide
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Embutramide
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
  • Intrapulmonary use
    • Dog
    • Cat
  • Intracardiac use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AX50
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V. Subsidiary In The Republic Of Croatia
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/22-01/230
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 7/08/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."